SCHEMBL21589205

SCHEMBL21589205

CCOC(=O)c1cnn2c(Br)ccc(CC)c12

nearest known ligand 0.47

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 7/20 0.47
KDM4E B2RXH2 6/20 0.47
NPC1 O15118 6/20 0.47
ALDH1A1 P00352 9/20 0.46
HPGD P15428 5/20 0.46
HIF1A Q16665 1/20 0.46
SMN1; SMN2 Q16637 5/20 0.45
TSHR P16473 2/20 0.45
HSD17B10 Q99714 2/20 0.44
MAPT P10636 3/20 0.43
NFKB1 P19838 1/20 0.42
NFKB2 Q00653 1/20 0.42
RELA Q04206 1/20 0.42
LMNA P02545 1/20 0.41
KMT2A Q03164 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21585782 0.85 ALDH1A1 (0.46) RAB9AKDM4ENPC1ALDH1A1HPGD
SCHEMBL13850894 0.78 RAB9A (0.47) RAB9AKDM4ENPC1ALDH1A1HPGD
SCHEMBL3203987 0.78 ALDH1A1 (0.46) RAB9AKDM4ENPC1ALDH1A1HPGD
SCHEMBL20265295 0.78 RAB9A (0.49) RAB9AKDM4ENPC1ALDH1A1HPGD
SCHEMBL25343568 0.74 ALDH1A1 (0.50) RAB9AKDM4ENPC1ALDH1A1HPGD
SCHEMBL25344717 0.74 RAB9A (0.45) RAB9AKDM4ENPC1ALDH1A1HPGD
SCHEMBL30926481 0.72 RAB9A (0.49) RAB9AKDM4ENPC1ALDH1A1HPGD
SCHEMBL2315523 0.72 RAB9A (0.48) RAB9AKDM4ENPC1ALDH1A1HPGD
SCHEMBL5069717 0.71 ALDH1A1 (0.71) RAB9AKDM4ENPC1ALDH1A1HPGD
SCHEMBL31329788 0.71 RAB9A (0.45) RAB9AKDM4ENPC1ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3802539-B1 TETRAHYDRO-1H-PYRAZINO[2,1-A]ISOINDOLYLQUINOLINE COMPOUNDS FOR THE TREATMENT OF AUTOIMMUNE DISEASE HOFFMANN LA ROCHE (CH) 2023-09-20 EP disclosed
WO-2019233941-A1 TETRAHYDRO-1 H-PYRAZINO[2,1 -AJISOINDOLYLQUINOLINE COMPOUNDS FOR THE TREATMENT OF AUTOIMMUNE DISEASE F. HOFFMANN-LA ROCHE AG (CH) 2019-12-12 WO disclosed